Book an online medical consultation to discuss your weight, health history and available weight-management options. A licensed doctor will assess whether prescription treatment, including Mounjaro where appropriate, may be suitable for you.
The consultation fee covers the medical assessment only. Medication is not included. MobiDoctor does not sell or dispense medicines. Any prescription is issued solely at the treating doctor’s discretion, and you must obtain and pay for prescribed medication separately at a pharmacy.
Book an online weight-management consultation
Dr. Chrysoula I. Liakou MD, PhD
Mounjaro (tirzepatide) is a prescription medicine that may be considered for weight management in certain adults. Whether it is suitable for you can only be determined after an individual medical assessment.
Under its EU authorisation for weight management, tirzepatide may be considered for adults with:
A BMI of 30 or above, or
A BMI of 27 to under 30 together with at least one weight-related health condition
Examples of weight-related conditions can include high blood pressure, abnormal blood-fat levels, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes.
Meeting these criteria does not mean that Mounjaro will automatically be prescribed.
A licensed doctor will also consider factors such as:
Your medical and weight history
Existing health conditions
Current medicines
Previous weight-management approaches
Possible contraindications or precautions
The potential benefits and risks of available treatment options
Prescription weight-management medicines are not suitable for everyone. During an online consultation, the doctor can assess your individual circumstances and discuss the weight-management options that may be appropriate for you.
The outcome may include lifestyle advice, further investigations, follow-up, another treatment approach or prescription treatment where the doctor considers it appropriate.
Mounjaro is intended to be used alongside appropriate dietary and physical-activity measures when prescribed for weight management.
MobiDoctor provides the medical consultation only. Medication is not included in the consultation fee, and MobiDoctor does not sell or dispense Mounjaro or any other medicine. Any prescribing decision is made solely by the treating doctor following an individual medical assessment.
A licensed doctor reviews your health history, current medicines and relevant risk factors.
Follow-up can help assess side effects, tolerability and whether treatment remains appropriate.
Any decision to prescribe, adjust or continue treatment is made solely by the treating doctor.
Mounjaro (tirzepatide) is a prescription medicine that may be considered for weight management in certain adults. Whether it is suitable for you can only be determined after an individual medical assessment.
Under its EU authorisation for weight management, tirzepatide may be considered for adults with:
A BMI of 30 or above, or
A BMI of 27 to under 30 together with at least one weight-related health condition
Examples of weight-related conditions can include high blood pressure, abnormal blood-fat levels, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes.
Meeting these criteria does not mean that Mounjaro will automatically be prescribed.
A licensed doctor will also consider factors such as:
Your medical and weight history
Existing health conditions
Current medicines
Previous weight-management approaches
Possible contraindications or precautions
The potential benefits and risks of available treatment options
Prescription weight-management medicines are not suitable for everyone. During an online consultation, the doctor can assess your individual circumstances and discuss the weight-management options that may be appropriate for you.
The outcome may include lifestyle advice, further investigations, follow-up, another treatment approach or prescription treatment where the doctor considers it appropriate.
Mounjaro is intended to be used alongside appropriate dietary and physical-activity measures when prescribed for weight management.
Like all prescription medicines, Mounjaro (tirzepatide) can cause side effects. The type and severity of side effects vary between individuals, and some are more common when treatment is first started or when the dose is increased.
The most commonly reported side effects are gastrointestinal and may include:
Nausea
Diarrhoea
Vomiting
Constipation
Abdominal pain or discomfort
Indigestion
Bloating
Reduced appetite
These effects are often mild to moderate and may improve over time.
If symptoms are persistent, worsening or make it difficult to eat or drink normally, medical advice should be sought.
Less common but potentially serious problems can occur.
These may include:
Pancreatitis: Severe and persistent abdominal pain, particularly if it spreads to the back, requires urgent medical assessment.
Severe dehydration: Persistent vomiting or diarrhoea can lead to dehydration and may affect kidney function.
Low blood sugar: The risk can increase when tirzepatide is used together with insulin or certain other diabetes medicines.
Serious allergic reaction: Difficulty breathing or significant swelling of the face, lips, tongue or throat requires emergency medical attention.
Gallbladder problems: Gallstones and other gallbladder conditions can occur in some patients.
Before prescribing tirzepatide, a doctor should review your medical history, current medicines and other factors that may affect whether treatment is appropriate.
Additional consideration may be needed if you:
Have previously had pancreatitis
Have significant gastrointestinal problems
Use insulin or medicines that can cause low blood sugar
Have kidney problems or an increased risk of dehydration
Have gallbladder disease
Are pregnant, planning pregnancy or breastfeeding
Have other medical conditions that may affect treatment
A previous history of pancreatitis does not automatically mean that treatment cannot be considered, but it may require additional medical assessment.
Depending on the symptoms, measures that may help include:
Eating smaller meals
Eating slowly and stopping when comfortably full
Maintaining adequate hydration
Avoiding unusually large or high-fat meals if these worsen symptoms
Following the dosing schedule provided by your doctor
Do not change your prescribed dose based on general online information. Speak with the treating doctor if side effects are persistent, worsening or difficult to manage.
If Mounjaro is prescribed, follow-up may be recommended to assess:
How well the treatment is tolerated
Changes in weight and relevant health measures
Any side effects
Whether the current dose remains appropriate
Whether treatment should be continued, adjusted or changed
The type and frequency of follow-up depend on the individual patient and their medical circumstances.
Mounjaro is a prescription-only medicine.
Mobidoctor provides medical consultations and does not sell or dispense Mounjaro or any other medicine. Any decision to prescribe, change or continue treatment is made solely by the treating doctor following an individual medical assessment.
Yes. You can book an online medical consultation with a licensed doctor to discuss your weight, medical history and available weight-management options. The doctor will assess whether prescription treatment may be appropriate for you.
Clinical studies show that tirzepatide may help reduce body weight when used alongside a healthy diet and regular activity. However, it is not licensed solely as a weight-loss medicine in all regions and must be prescribed only by a doctor following an appropriate clinical assessment.
Tirzepatide may be prescribed for adults with a body mass index (BMI) of 30 or higher, or 27 with associated conditions such as type 2 diabetes or hypertension. Suitability depends on individual health status, other medications, and medical history. Only a doctor can confirm eligibility.
Mounjaro is injected under the skin once weekly. The dose is usually started at 2.5 mg and gradually increased under medical supervision. A doctor determines the correct dosage and monitors progress and side effects throughout treatment.
Dr. Chrysoula I. Liakou MD, PhD